Phosphoramidites play a crucial role in nucleic acid chemistry, serving as indispensable reagents for the synthesis of DNA, RNA, and their modified analogs. These compounds also form the foundation of solid-phase oligonucleotide synthesis, facilitating the creation of sequences for research and drug development purposes. By providing high-purity phosphoramidites, we address the evolving needs of the pharmaceutical and biotechnology industries, ensuring that researchers have access to reliable, high-performance reagents.
Overview of Phosphoramidites: Structure and Function
Phosphoramidites are nucleoside derivatives functionalized with a reactive phosphite group, protected hydroxyl groups, and a leaving group. Their design ensures controlled, stepwise elongation of oligonucleotide chains during automated synthesis. Each phosphoramidite monomer couples to the growing oligonucleotide via a highly efficient reaction, followed by oxidation to stabilize the phosphate backbone. This process allows for the rapid assembly of sequences up to 200 nucleotides in length. Beyond standard DNA/RNA synthesis, phosphoramidites are engineered to incorporate modified bases, linkers, or labels, expanding their utility in advanced applications such as gene editing and targeted drug delivery.
Fig 1. Synthetic route of a specific phosphoramidite reagent (Osawa, et al., 2022).
Classification of Phosphoramidites
Standard Nucleoside Phosphoramidites
These include the four canonical DNA bases (dA, dT, dC, dG) and RNA bases (rA, rU, rC, rG), each protected with standard groups (e.g., DMTr for 5'-OH, benzoyl/acetyl for exocyclic amines). They are optimized for routine synthesis of unmodified oligonucleotides with >99.5% coupling efficiency.
Modified Nucleoside Phosphoramidites
Base-Modified Phosphoramidites: Fluorescent tags (FAM, Cy5), methylation (5-methyl-dC), or hydrophobic groups for enhanced stability or detection.
Sugar-Modified Phosphoramidites: 2'-O-methyl, 2'-fluoro, or locked nucleic acid (LNA) variants to improve nuclease resistance and binding affinity.
Backbone-Modified Phosphoramidites: Phosphorothioate or boranophosphate linkages for therapeutic oligonucleotides requiring altered pharmacokinetic profiles.
Functionalized Phosphoramidites
These monomers feature reactive groups (azide, alkyne, thiol) or conjugation handles (biotin, cholesterol) for post-synthesis modification. They enable site-specific attachment of peptides, lipids, or small molecules, facilitating the development of multifunctional oligonucleotide conjugates.
Specialty Phosphoramidites
Cleavable Phosphoramidites: Incorporate disulfide or photocleavable linkers for controlled release in drug delivery systems.
Universal Phosphoramidites: Degenerate bases (inosine) or spacers (C3, hexanediol) for degenerate library synthesis or structural flexibility.
Applications of Phosphoramidites
Antisense Oligonucleotides (ASOs) and siRNA Therapeutics
Phosphoramidites enable the synthesis of ASOs and small interfering RNAs (siRNAs) that modulate gene expression by targeting mRNA. Modified phosphoramidites (e.g., 2'-MOE, LNA) enhance target binding and reduce off-target effects, critical for treating genetic disorders, cancers, and viral infections.
Aptamer Development
High-affinity aptamers rely on phosphoramidites with diverse modifications to achieve specificity for proteins, cells, or small molecules. These molecules are explored as targeted drug delivery vehicles or diagnostic biosensors.
mRNA Vaccine and Therapeutic Production
Beyond DNA, phosphoramidites facilitate the synthesis of modified mRNA components, such as cap structures or codon-optimized sequences, improving translational efficiency and immunogenicity in vaccines.
Diagnostic Probes and Primers
Fluorescently labeled phosphoramidites are used to synthesize probes for PCR, FISH, or microarray assays. Custom primers with phosphorothioate ends or overhangs support advanced cloning and sequencing workflows.
Drug Delivery Systems
Conjugation-ready phosphoramidites allow the attachment of targeting ligands (e.g., antibodies, folate) or lipid moieties to oligonucleotides, enhancing cellular uptake and tissue-specific delivery.
By providing high-quality phosphoramidites, we empower researchers to explore and develop new pharmaceutical applications in the rapidly advancing field of nucleic acid-based science.
Reference
- Osawa, T.; et al. Development of phosphoramidite reagents for the synthesis of base-labile oligonucleotides modified with a linear aminoalkyl and amino-PEG linker at the 3’-end. Molecules. 2022, 27(23): 8501.